Site activation refers to the process of preparing and authorizing a clinical research site to begin enrolling participants in a study. This crucial step involves completing all necessary regulatory, administrative, and logistical requirements to ensure the site is fully equipped to conduct the trial according to the protocol.
The activation process typically includes tasks such as obtaining institutional review board (IRB) approval, finalizing contracts and budgets, training study staff, and setting up essential equipment and supplies. Once a site is activated, it can officially start screening and enrolling participants, marking the commencement of the active phase of the clinical trial at that location.
Site activation is a critical milestone in clinical research as it directly impacts the timeline and success of a study. Efficient site activation can accelerate participant enrollment, reduce overall study duration, and potentially lead to faster drug or treatment approvals.
Understanding site activation is crucial for sponsors, CROs, and site staff to effectively manage resources and expectations. It helps identify potential bottlenecks in study initiation, allowing for proactive problem-solving and streamlined processes across multiple research sites.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant